Urology News and Research

Latest Urology News and Research

Author evaluates potential benefits of IAD for treating prostate cancer

'Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature' is the title of an article by P-A. Abrahamsson in the January issue of European Urology, the official journal of the European Association of Urology. The author evaluates available evidence regarding the efficacy and tolerability of intermittent androgen deprivation (IAD) and assess its value in the treatment of prostate cancer (PCa).

5 Jan 2010

Androgen receptor plays critical role in wound healing

A molecular receptor pivotal to the action of male hormones such as testosterone also plays a crucial role in the body's ability to heal, report scientists in the December issue of the Journal of Clinical Investigation.

5 Jan 2010

Warner Chilcott accepts $290.5 million in tender offer for its 8-3/4% Senior Subordinated Notes due 2015

Warner Chilcott plc today announced that its subsidiary Warner Chilcott Corporation (the "Company") has received and accepted for purchase approximately $290.5 million aggregate principal amount of its 8-3/4% Senior Subordinated Notes due 2015 (Cusip No. 93443MAC5) (the "Notes") validly tendered by 11:59 p.m., New York City time, on Tuesday, December 29, 2009, (the "Consent Date"), and has received consents from holders of approximately 76% of the Notes as of the Consent Date.

31 Dec 2009

JumpStart announces two JumpStart Ventures investments

JumpStart Inc., the Northeast Ohio venture development organization that accelerates the progress of high growth early-stage businesses, announces two JumpStart Ventures investments.

31 Dec 2009

LUHS urogynecologists awarded $1M NIH Challenge Grant

The National Institutes of Health (NIH) has awarded a Challenge Grant for $1 million to Loyola University Health System (LUHS) urogynecologists Kimberly Kenton, MD, and Elizabeth Mueller, MD. This places them among the top 2 percent of researchers in the nation to receive this grant.

24 Dec 2009

Researchers develop new approach for treating and healing skin abscesses

Researchers at the Albert Einstein College of Medicine of Yeshiva University have developed a new approach for treating and healing skin abscesses caused by bacteria resistant to most antibiotics.

23 Dec 2009

U.S. Congress approves $1.6 million for AdMeTech Foundation's research program

AdMeTech Foundation, a nonprofit organization, announced today that the U.S. Congress has approved $1.6 million for funding of its groundbreaking research program aimed at developing novel imaging technologies for early prostate cancer detection, which in turn is critical for saving lives and designing customized patient care, including the most effective and the least invasive approach.

23 Dec 2009

LA BioMed physician-researchers named Super Doctors in the Los Angeles Magazine

Los Angeles Magazine, in its January issue, will name 37 of the physician-researchers at Los Angeles Biomedical Research Institute (LA BioMed) to be among Southern California Super Doctors.

22 Dec 2009

Urigen Pharmaceuticals and Oceana Therapeutics jointly prepare for meeting with FDA on URG101

Urigen Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced today that the Company and Oceana Therapeutics have agreed to jointly prepare for a meeting with the U.S. Food & Drug Administration regarding the continued development of URG101.

22 Dec 2009

Ambit Biosciences and Astellas Pharma to jointly develop and commercialize FLT3 kinase inhibitors

Ambit Biosciences Corporation and Astellas Pharma Inc. today announced that they have entered into a worldwide agreement to jointly develop and commercialize FLT3 kinase inhibitors in oncology and non-oncology indications.

18 Dec 2009

Portable bladder volume ultrasound now included in 2009 CDC guidelines for the prevention CA-UTIs

Verathon®, maker of BladderScan® bladder volume instruments is pleased to announce that portable bladder volume ultrasound is now included in the new 2009 CDC guidelines for the Prevention of Catheter-Associated Urinary Tract Infections (CA-UTIs).

17 Dec 2009

Ethicon and Acclarent announce definitive merger agreement

Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.

17 Dec 2009

Positive results from Auxilium Pharmaceuticals' XIAFLEX Peyronie's disease phase IIb trial

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced top-line efficacy and safety results for the phase IIb clinical trial for XIAFLEX™ (collagenase clostridium histolyticum) in the treatment of Peyronie's disease.

16 Dec 2009

Warner Chilcott begins cash tender offer

Warner Chilcott plc today announced that its subsidiary Warner Chilcott Corporation (the "Company") has commenced a cash tender offer, on the terms and subject to the conditions set forth in the Company's Offer to Purchase and Consent Solicitation Statement dated December 15, 2009 (the "Offer to Purchase"), for any and all of its outstanding 8.75% senior subordinated notes due 2015 (the "Notes").

16 Dec 2009

Zecotek Photonics' proprietary TGFL selected for research in flow cytometry

Zecotek Photonics Inc., a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the National Cancer Institute, a division of the U.S. National Institutes of Health (NIH), has selected its proprietary Tunable Green Fiber Laser (TGFL) for research in flow cytometry.

16 Dec 2009

Pure populations of immature cells that enable male reproduction isolated and transplanted

Reproductive researchers from the University of Pennsylvania and The Children's Hospital of Philadelphia have succeeded in isolating and transplanting pure populations of the immature cells that enable male reproduction in two species-human spermatogonia and mouse gonocytes. These germline stem cells, taken from testis biopsies, demonstrated viability following transplantation to mouse testes within a controlled laboratory setting.

15 Dec 2009

New program to help maintain bone health in men with prostate cancer on ADT announced

Watson Pharmaceuticals, Inc. today announced a new program encouraging health professionals to help maintain the bone health of prostate cancer patients who are on long-term androgen deprivation therapy (ADT).

15 Dec 2009

LABORIE and meridianEMR integrate their EMR and Urodynamic system for Urologists

As the U.S. ramps up the implementation of EMRs in medical practices in order to lower costs, prevent errors, and improve patient care, meridianEMR and LABORIE MEDICAL have provided a great benefit to Urologists using LABORIE urodynamic systems.

14 Dec 2009

Tulane Cancer Center starts randomizing patients in phase III clinical study of Alpharadin

Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.

14 Dec 2009

Uroplasty to publish 12-month results of its OrBIT Urgent PC Neuromodulation System trial

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted the 12-month results of the OrBIT Trial of its Urgent® PC Neuromodulation System that will be published in the January 2010 print edition of THE JOURNAL OF UROLOGY®.

10 Dec 2009

Urology News and Research

Latest Urology News and Research

Author evaluates potential benefits of IAD for treating prostate cancer

Androgen receptor plays critical role in wound healing

Warner Chilcott accepts $290.5 million in tender offer for its 8-3/4% Senior Subordinated Notes due 2015

JumpStart announces two JumpStart Ventures investments

LUHS urogynecologists awarded $1M NIH Challenge Grant

Researchers develop new approach for treating and healing skin abscesses

U.S. Congress approves $1.6 million for AdMeTech Foundation's research program

LA BioMed physician-researchers named Super Doctors in the Los Angeles Magazine

Urigen Pharmaceuticals and Oceana Therapeutics jointly prepare for meeting with FDA on URG101

Ambit Biosciences and Astellas Pharma to jointly develop and commercialize FLT3 kinase inhibitors

Portable bladder volume ultrasound now included in 2009 CDC guidelines for the prevention CA-UTIs

Ethicon and Acclarent announce definitive merger agreement

Positive results from Auxilium Pharmaceuticals' XIAFLEX Peyronie's disease phase IIb trial

Warner Chilcott begins cash tender offer

Zecotek Photonics' proprietary TGFL selected for research in flow cytometry

Pure populations of immature cells that enable male reproduction isolated and transplanted

New program to help maintain bone health in men with prostate cancer on ADT announced

LABORIE and meridianEMR integrate their EMR and Urodynamic system for Urologists

Tulane Cancer Center starts randomizing patients in phase III clinical study of Alpharadin

Uroplasty to publish 12-month results of its OrBIT Urgent PC Neuromodulation System trial

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Urology News and Research

Latest Urology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in